{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"new-onset-refractory-status-epilepticus","columns":[{"gene":"","key":"population-941a68ed3443df262778","label":"New-onset refractory status epilepticus","mondoId":"MONDO:0018199","onsetQualifier":null,"originColumnKey":"MONDO:0018199/ORPHA:363558","originalViews":[{"key":"MONDO:0018199/ORPHA:363558","label":"New-onset refractory status epilepticus","scopeLabel":"ORPHA:363558","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["03276bf0f53c2e807114d096399ba7e51f62d10cc0cc17b76a31728bf451f6e8","05ab3938c70a200b86802ab77a6d3a3a52625146e57abdfca50086a8c2a69658","0a2c7aab8f06c0036882aaf248a94e9bb1607f1ca94e86763e13e48e74a5e2e1","0bd422b9e6eaa70053c77f30e3a74d7d22af8f93f5e4618d3ceb71db380abfe0","16d0c6bd52d6b655c83fab0fa982e32af91cd2003ef2c2b6b03b673110510596","45376d8a5b0d6293c08407aff9f1973f4414a5968a62fe1dd2efe0216082b1eb","4fc714c17a5ff065626713d6ed46f065ba01d4441525bd549e9a9d693afc7ffb","59bc5c89da8df49a2f94a2ee62ef01780510d197326371dbb739a9a46b7b2b55","5a4cd43389d9cc706fd410aab11ecc26d130a16bd390b88d1f200d4fb8d0f293","5d6fcf2176a1593709e13f2b950747729d69354f94433713a8c79e6e10fb75ad","619da5259d51b6184e185ad99bb1a8f32dea07e76ff929c8e01d4aa9b725c2e8","6236f72ea06e8ee0f8772dd11d1e7dbbb247b6048ca4102c79cd5b2de3c49d15","6535c2017ca97d51d12d6d9a7128ff6f07be66fb508dcdf1b616dca18ed4477f","68e8a0af461e81e4494b971adf44ae66cba1ee4b4de5e8091bfd17b57096fa81","74691fee973b90a5ebe372d44d6c4142ed46db6f84ab08570534a7919b401895","79b8af8feb30498e944a7e26b7081c3f70fbff71aebedd90b5bd4144bd13f3a5","7b8d1f4ec4af6d40b18da974a40bc63d3dd531a109f49463dc0f255b366a7e61","7fffede4e11bef8d3be669115fc51c17cc8d9a2e0a89ced5eebf4e4b862a53e1","817461451b3485cf34735ccea780ac90e5e5dd4bba436c0ca87c2f89fc4ebe37","8b747119dd1b6b3d70ec176cab37a0263a1dca6571d71f2d94905e31c5f6a604","8e7f4f948fc0cba6e9f6c79e4b900871cdfb925289208f4d27f0b64142a42e4e","905fb55ee5875be802ea85fa290f55b3e29fb8db80455f2694b04cc508a9a521","97447a864cb94a2c5d50349838d504c20ef56fa8a2ce9dbbfb23b7908be976d2","9d39e227a8810f1d2ea7f46a370ae270438841734a74db4cd0a4bb239288fd3a","a3d7f6c8d1edafc85a82f43e6d98fcc480edbc836de3ce7df0259ca484d13ce3","bc5bb145435b6dcec9b7d09bc9f6899faf1735c99e695696d2a79179d6fbcbcd","c029b94334ae4a67d3b40b03c9415bc6149a8e7a31c1da992784c35e2f381c4f","c12af2e606dbf9b3483a2f7caae2246430c68c0318f3faeff1b9de282f4ebeeb","c4cda41e3797575f238421640b78a745263fa90ad7f1dc93262aa018bb638053","d321613e5ec460148801a08b91a72ce17f65ba3021d467a81942108440ffa9da","dd93cefe8260ac1f7e3847fe8d3845f4e65f50423447d1b3f3cbbc79b8920b72","e172aa84d93949a1935dbb166384c787d181be7643f4e9ba35a2ad5cd163bb64","e77c9cd13ca2d0d984f9bb9fe645e7dbd69ddb2842e1dca5729348d6cdcaac5a","ece08922c12273c7a16d8d5e15f5a97f1af75c9a39e19032982f1075dc28b89d","ef89027bcb517d18874eb0b725396d084874231f02d42950ddca7f0b580d5a18","f220fd039e20ebfa60c1e57b65af54ea6eb3dc2c568595bbc039452311908518","fee6d38198ce178f36cf9586d8e3b42461fc9e04398b5ce6380b92e52a3f7917"],"recordQualifiers":{},"scopeLabel":"ORPHA:363558","sourceIds":["ORPHA:363558"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-941a68ed3443df262778"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012751","HP:0011117","HP:0002457","HP:0012696","HP:0000708","HP:0002960","HP:0007334"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":37,"sourceGroups":{"orphanet":37}},"features":[{"hpoId":"HP:0012751","label":"Abnormal basal ganglia MRI signal intensity","primary":true},{"hpoId":"HP:0011117","label":"Abnormal circulating interleukin concentration","primary":true},{"hpoId":"HP:0002457","label":"Abnormal head movements","primary":true},{"hpoId":"HP:0012696","label":"Abnormal thalamic MRI signal intensity","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0007334","label":"Bilateral tonic-clonic seizure with focal onset","primary":true},{"hpoId":"HP:0410263","label":"Brain imaging abnormality","primary":false},{"hpoId":"HP:0030915","label":"Cerebellar edema","primary":false},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:0001289","label":"Confusion","primary":false},{"hpoId":"HP:0012229","label":"CSF pleocytosis","primary":false},{"hpoId":"HP:0033716","label":"EEG with frontal epileptiform discharges","primary":false},{"hpoId":"HP:0011198","label":"EEG with generalized epileptiform discharges","primary":false},{"hpoId":"HP:0010845","label":"EEG with generalized slow activity","primary":false},{"hpoId":"HP:0010850","label":"EEG with spike-wave complexes","primary":false},{"hpoId":"HP:0033717","label":"EEG with temporal epileptiform discharges","primary":false},{"hpoId":"HP:0011468","label":"Facial tics","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0001945","label":"Fever","primary":false},{"hpoId":"HP:0011154","label":"Focal autonomic seizure","primary":false},{"hpoId":"HP:0020217","label":"Focal aware motor seizure","primary":false},{"hpoId":"HP:0002384","label":"Focal impaired awareness seizure","primary":false},{"hpoId":"HP:0007183","label":"Focal T2 hyperintense basal ganglia lesion","primary":false},{"hpoId":"HP:0004302","label":"Functional motor deficit","primary":false},{"hpoId":"HP:0002283","label":"Global brain atrophy","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0002922","label":"Increased CSF protein concentration","primary":false},{"hpoId":"HP:0002383","label":"Infectious encephalitis","primary":false},{"hpoId":"HP:0025373","label":"Interictal EEG abnormality","primary":false},{"hpoId":"HP:0010841","label":"Multifocal epileptiform discharges","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0032867","label":"Refractory status epilepticus","primary":false},{"hpoId":"HP:0032894","label":"Seizure precipitated by febrile infection","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0031475","label":"Status epilepticus without prominent motor symptoms","primary":false},{"hpoId":"HP:0031358","label":"Vegetative state","primary":false}],"ledeHtml":"New-onset refractory status epilepticus (NORSE) occurs when a person without a previous history of seizures, experiences status epilepticus (SE) without a clear cause. SE describes a state in which a person has one prolonged seizure, or a cluster of seizures without recovery time in between. The symptoms of NORSE typically begin with a mild fever and general symptoms of illness. People with NORSE may also experience behavioral and cognitive symptoms. SE associated with NORSE can last days, weeks, or months and may lead to a comatose state. A likely cause is identified in about half of all people with NORSE. The most common causes of NORSE include autoimmune disorders, paraneoplastic disorders, and viral encephalitis. Studies indicate that changes in certain genes, including the SCN2A and IL1RN gene(s) may increase the risk to develop NORSE. When the cause cannot be found, cryptogenic NORSE is diagnosed. Most people with cryptogenic NORSE experience a fever prior to seizure development. These cases are classified as a sub-type of NORSE, called Febrile Infection-Related Epilepsy Syndrome (FIRES). A diagnosis of NORSE is suspected in people who develop SE that does not respond to typical treatment and that does not have an obvious cause. A diagnostic work-up may include brain imaging, cerebrospinal fluid studies, and blood tests. Electroencephalography (EEG) is used to monitor seizures throughout the illness.","mondoId":"MONDO:0018199","node":{"canonicalSlug":"new-onset-refractory-status-epilepticus","comparisons":[{"documentSha256":"4014b0554eb9af1316154de700ef6b74eb78c4b0f17dfff95aef35337b9557fc","key":"legacy-new-onset-refractory-status-epilepticus","kind":"legacy","label":"new-onset refractory status epilepticus","memberIds":["MONDO:0018199"],"mondoId":"MONDO:0018199","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/new-onset-refractory-status-epilepticus.4014b0554eb9af1316154de700ef6b74eb78c4b0f17dfff95aef35337b9557fc.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"New-onset refractory status epilepticus","originalSourceId":"ORPHA:363558","paragraphs":["New-onset refractory status epilepticus (NORSE) occurs when a person without a previous history of seizures, experiences status epilepticus (SE) without a clear cause. SE describes a state in which a person has one prolonged seizure, or a cluster of seizures without recovery time in between. The symptoms of NORSE typically begin with a mild fever and general symptoms of illness. People with NORSE may also experience behavioral and cognitive symptoms. SE associated with NORSE can last days, weeks, or months and may lead to a comatose state. A likely cause is identified in about half of all people with NORSE. The most common causes of NORSE include autoimmune disorders, paraneoplastic disorders, and viral encephalitis. Studies indicate that changes in certain genes, including the SCN2A and IL1RN gene(s) may increase the risk to develop NORSE. When the cause cannot be found, cryptogenic NORSE is diagnosed. Most people with cryptogenic NORSE experience a fever prior to seizure development. These cases are classified as a sub-type of NORSE, called Febrile Infection-Related Epilepsy Syndrome (FIRES). A diagnosis of NORSE is suspected in people who develop SE that does not respond to typical treatment and that does not have an obvious cause. A diagnostic work-up may include brain imaging, cerebrospinal fluid studies, and blood tests. Electroencephalography (EEG) is used to monitor seizures throughout the illness."],"rawAttribution":"MONDO:0018199","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:39Z","upstream":"GARD:0012244","url":"https://rarediseases.info.nih.gov/diseases/12244"},"ownColumnKeys":["population-941a68ed3443df262778"],"publication":"published","relationships":[{"kind":"parent","label":"childhood-onset epilepsy syndrome","mondoId":"MONDO:0020072","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"03276bf0f53c2e807114d096399ba7e51f62d10cc0cc17b76a31728bf451f6e8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002283","is_excluded":false,"label":"Global brain atrophy","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"05ab3938c70a200b86802ab77a6d3a3a52625146e57abdfca50086a8c2a69658","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0032867","is_excluded":false,"label":"Refractory status epilepticus","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a2c7aab8f06c0036882aaf248a94e9bb1607f1ca94e86763e13e48e74a5e2e1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0bd422b9e6eaa70053c77f30e3a74d7d22af8f93f5e4618d3ceb71db380abfe0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"16d0c6bd52d6b655c83fab0fa982e32af91cd2003ef2c2b6b03b673110510596","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010841","is_excluded":false,"label":"Multifocal epileptiform discharges","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"45376d8a5b0d6293c08407aff9f1973f4414a5968a62fe1dd2efe0216082b1eb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002383","is_excluded":false,"label":"Infectious encephalitis","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4fc714c17a5ff065626713d6ed46f065ba01d4441525bd549e9a9d693afc7ffb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002384","is_excluded":false,"label":"Focal impaired awareness seizure","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"59bc5c89da8df49a2f94a2ee62ef01780510d197326371dbb739a9a46b7b2b55","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012696","is_excluded":false,"label":"Abnormal thalamic MRI signal intensity","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5a4cd43389d9cc706fd410aab11ecc26d130a16bd390b88d1f200d4fb8d0f293","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010850","is_excluded":false,"label":"EEG with spike-wave complexes","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d6fcf2176a1593709e13f2b950747729d69354f94433713a8c79e6e10fb75ad","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0031475","is_excluded":false,"label":"Status epilepticus without prominent motor symptoms","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"619da5259d51b6184e185ad99bb1a8f32dea07e76ff929c8e01d4aa9b725c2e8","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011117","is_excluded":false,"label":"Abnormal circulating interleukin concentration","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6236f72ea06e8ee0f8772dd11d1e7dbbb247b6048ca4102c79cd5b2de3c49d15","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0020217","is_excluded":false,"label":"Focal aware motor seizure","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6535c2017ca97d51d12d6d9a7128ff6f07be66fb508dcdf1b616dca18ed4477f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011198","is_excluded":false,"label":"EEG with generalized epileptiform discharges","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"68e8a0af461e81e4494b971adf44ae66cba1ee4b4de5e8091bfd17b57096fa81","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030915","is_excluded":false,"label":"Cerebellar edema","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"74691fee973b90a5ebe372d44d6c4142ed46db6f84ab08570534a7919b401895","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0012751","is_excluded":false,"label":"Abnormal basal ganglia MRI signal intensity","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"79b8af8feb30498e944a7e26b7081c3f70fbff71aebedd90b5bd4144bd13f3a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031358","is_excluded":false,"label":"Vegetative state","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b8d1f4ec4af6d40b18da974a40bc63d3dd531a109f49463dc0f255b366a7e61","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7fffede4e11bef8d3be669115fc51c17cc8d9a2e0a89ced5eebf4e4b862a53e1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002922","is_excluded":false,"label":"Increased CSF protein concentration","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"817461451b3485cf34735ccea780ac90e5e5dd4bba436c0ca87c2f89fc4ebe37","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b747119dd1b6b3d70ec176cab37a0263a1dca6571d71f2d94905e31c5f6a604","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0033717","is_excluded":false,"label":"EEG with temporal epileptiform discharges","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8e7f4f948fc0cba6e9f6c79e4b900871cdfb925289208f4d27f0b64142a42e4e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001289","is_excluded":false,"label":"Confusion","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"905fb55ee5875be802ea85fa290f55b3e29fb8db80455f2694b04cc508a9a521","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004302","is_excluded":false,"label":"Functional motor deficit","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"97447a864cb94a2c5d50349838d504c20ef56fa8a2ce9dbbfb23b7908be976d2","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9d39e227a8810f1d2ea7f46a370ae270438841734a74db4cd0a4bb239288fd3a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0032894","is_excluded":false,"label":"Seizure precipitated by febrile infection","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3d7f6c8d1edafc85a82f43e6d98fcc480edbc836de3ce7df0259ca484d13ce3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011154","is_excluded":false,"label":"Focal autonomic seizure","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bc5bb145435b6dcec9b7d09bc9f6899faf1735c99e695696d2a79179d6fbcbcd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007183","is_excluded":false,"label":"Focal T2 hyperintense basal ganglia lesion","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c029b94334ae4a67d3b40b03c9415bc6149a8e7a31c1da992784c35e2f381c4f","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011468","is_excluded":false,"label":"Facial tics","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c12af2e606dbf9b3483a2f7caae2246430c68c0318f3faeff1b9de282f4ebeeb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007334","is_excluded":false,"label":"Bilateral tonic-clonic seizure with focal onset","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c4cda41e3797575f238421640b78a745263fa90ad7f1dc93262aa018bb638053","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d321613e5ec460148801a08b91a72ce17f65ba3021d467a81942108440ffa9da","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dd93cefe8260ac1f7e3847fe8d3845f4e65f50423447d1b3f3cbbc79b8920b72","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e172aa84d93949a1935dbb166384c787d181be7643f4e9ba35a2ad5cd163bb64","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012229","is_excluded":false,"label":"CSF pleocytosis","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e77c9cd13ca2d0d984f9bb9fe645e7dbd69ddb2842e1dca5729348d6cdcaac5a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0033716","is_excluded":false,"label":"EEG with frontal epileptiform discharges","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ece08922c12273c7a16d8d5e15f5a97f1af75c9a39e19032982f1075dc28b89d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002457","is_excluded":false,"label":"Abnormal head movements","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ef89027bcb517d18874eb0b725396d084874231f02d42950ddca7f0b580d5a18","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0025373","is_excluded":false,"label":"Interictal EEG abnormality","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f220fd039e20ebfa60c1e57b65af54ea6eb3dc2c568595bbc039452311908518","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010845","is_excluded":false,"label":"EEG with generalized slow activity","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fee6d38198ce178f36cf9586d8e3b42461fc9e04398b5ce6380b92e52a3f7917","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363558","disease_name":"New-onset refractory status epilepticus","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0410263","is_excluded":false,"label":"Brain imaging abnormality","onset_id":null,"reference":"ORPHA:363558","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12244\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018199\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0012244</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>New-onset refractory status epilepticus (NORSE) occurs when a person without a previous history of seizures, experiences status epilepticus (SE) without a clear cause. SE describes a state in which a person has one prolonged seizure, or a cluster of seizures without recovery time in between. The symptoms of NORSE typically begin with a mild fever and general symptoms of illness. People with NORSE may also experience behavioral and cognitive symptoms. SE associated with NORSE can last days, weeks, or months and may lead to a comatose state. A likely cause is identified in about half of all people with NORSE. The most common causes of NORSE include autoimmune disorders, paraneoplastic disorders, and viral encephalitis. Studies indicate that changes in certain genes, including the SCN2A and IL1RN gene(s) may increase the risk to develop NORSE. When the cause cannot be found, cryptogenic NORSE is diagnosed. Most people with cryptogenic NORSE experience a fever prior to seizure development. These cases are classified as a sub-type of NORSE, called Febrile Infection-Related Epilepsy Syndrome (FIRES). A diagnosis of NORSE is suspected in people who develop SE that does not respond to typical treatment and that does not have an obvious cause. A diagnostic work-up may include brain imaging, cerebrospinal fluid studies, and blood tests. Electroencephalography (EEG) is used to monitor seizures throughout the illness.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12244\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"new-onset-refractory-status-epilepticus","sourceDocuments":[{"name":"GARD: New-onset refractory status epilepticus","reviewed":null,"source_release":"2026-10-21T16:59:39Z","url":"https://rarediseases.info.nih.gov/diseases/12244"},{"name":"MONDO: new-onset refractory status epilepticus","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018199"}],"sourceNote":"","synonyms":["De novo cryptogenic refractory multifocal febrile status epilepticus","New onset refractory status epilepticus","NORSE","Norse"],"takeawayHtml":"","title":"new-onset refractory status epilepticus"},"schemaVersion":1}
